Overview
Synthego provides CRISPR genome engineering platform solutions from discovery to clinic, including synthetic sgRNA manufactured via proprietary methods for RUO, IND-enabling, and GMP grades compatible with nucleases like SpCas9, Cas12a, and MAD7. They offer cGMP CRISPR nucleases, high-performance IVT enzymes such as T7 RNA Polymerase and RNase Inhibitor, and molecular reagents for diagnostics, PCR, RNA synthesis, and CRISPR workflows. Synthego supports scalable gene editing with protein and mRNA formats and expanded manufacturing for cell and gene therapies.
Frequently asked questions
- What CRISPR products and grades does Synthego offer?
- Synthego offers synthetic sgRNA via proprietary manufacturing for RUO, IND-enabling, and GMP grades, supporting nucleases like SpCas9, Cas12a, Cas12b, and MAD7 in lengths from 40-120 mer, plus cGMP nucleases such as hfCas12Max.
- Does Synthego provide GMP-compliant solutions for clinical use?
- Yes, Synthego delivers best-in-class cGMP gRNAs and nucleases with proven clinical results, platform production processes, and a new facility to accelerate CRISPR-mediated cell and gene therapies.
- What additional reagents support Synthego's CRISPR workflows?
- Synthego provides high-performance IVT enzymes like T7 RNA Polymerase and RNase Inhibitor for RNA therapeutics, plus molecular reagents for diagnostics research, PCR, RNA synthesis, and CRISPR delivery in protein/mRNA formats.